Noel Relief Centers uses Extracorporeal Shockwave Therapy (ESWT) which is a non-invasive procedure that accelerates the recovery of injured tissue. ESWT typically has a 76 - 91% success rate for most conditions listed below.
To help improve the quality and quantity of our patients lives, and to support them in creating a healthier lifestyle for themselves and their families.
“I began seeing Dr. Noel after my back became so painful I could barely function. As the therapy program progressed, my neck and back became more pain-free and looser...I am very thankful that after many years of suffering that my condition has improved considerably.” - GeneRead More...
Extracorporeal Shockwave Therapy (ESWT) is approved in the US by the Food and Drug Administration (FDA) for treatment of plantar fasciitis and tennis elbow. There is an FDA study to treat recalcitrant diabetic wounds. The FDA approved Storz Medical's Duolith SD1 -T-TOP device to administer ESWT.
The UK advisory body, the National Institute for Health and Care Excellence (NICE), have issued guidance on ESWT to UK clinicians for a number of clinical indications including calcific tendinitis of the shoulder, refractory plantar fascitiis, refractory Achilles tendinopathy, refractory tennis elbow, and refractory greater trochanteric pain syndrome.
By: Alastair Younger, MB, ChB, FRCSC
Journal of American Medical Association, 2003
The American Journal of Sports MedicineRead More
Society for Experimental Biology